Matti Karvonen
VP Drug Development, Chief Medical Officer
Pharmaceutical Sciences
Faron Pharmaceuticals
Finland
Biography
MD, PhD with a background in clinical neurology; holds also an eMBA Solid medical experience in many international pharmaceutical organisations Responsible for overseeing Faron´s drug development strategy and central role in expanding the clinical programmes of Traumakine® and Clevegen
Research Interest
Pharmaceutical Sciences
